Selecting the correct vendors to support your UX project is critical to success. From facilities to recruiting, knowing the right questions to ask, budget constraints, and client needs and expectations will make the selection process smooth and painless.
Back to team page
Conor Mackin
Partner
With a background in human factors and over ten years of experience leading UX research, Conor is versed in both qualitative and quantitative research methods. He has worked in a variety of domains including defense, healthcare, energy, aeronautical, oil & gas, connected homes, and connected buildings. Conor has supported both the formative and summative aspects of the design process while being a passionate advocate for the end user. He has a BS in Psychology from Eckerd College.



Bold facts
Learn more about

Something unique about you summed up in one sentence

Your favorite part of working at Bold Insight

In your spare time (or if you had spare time), you would absolutely do this:

How long have you been in the UX field?

Your favorite city in the world is...and why?

Your ultimate celebrity dinner party guest list would include:

Long-term personal or professional goal?

Any other facts to share?
Read our team’s latest bold insights
Reclassifying diabetes: 3 implications for product design
Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.
Designing your POS so it’s not a POS
Regardless of whether the interface is intended to be used by a customer (novice) or an employee (expert), the key is to ensure that the POS interface is designed for the intended audience. To do this, organizations should engage users throughout the design process.
FDA’s digital health precertification program emphasizes importance of post-market surveillance
Finding efficient ways to leverage post-market surveillance data to inform product development at an institutional level will be key for SaMD manufacturers seeking FDA precertification.